Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial by Ian M. Catlett, Lu Gao, Yanhua Hu, Subhashis Banerjee, James G. Krueger

Subjects: Get full text

Deucravacitinib Improved Interstitial Pneumonia Along with KL-6 Reduction in a Patient with Psoriasis: A Case Report by Mima Y, Ohtsuka T, Akiyama N, Norimatsu Y

Subjects: Get full text

Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin by Megan E. McNamara, PhD, Leonardo Tjahjono, MD

Subjects: Get full text

Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Subjects: Get full text

Effects of Rho inhibitors on membrane depolarization‐induced contraction of male rat caudal arterial smooth muscle by Kazuki Aida, Reiko Ishii‐Nozawa, Mitsuo Mita

Subjects: “…proline‐rich tyrosine kinase 2…”
Get full text

Inhibiting Pyk2/Src expression by miR-23b-3p suppressed liver cancer stem cell function and hepatic carcinoma progression by Meng Sha, Jiang Zhang, Jin-kai Liu, Xiao-ye Qu, Chuan Shen, Ying Tong, Jie Cao

Subjects: Get full text

Novel carbazole attenuates vascular remodeling through STAT3/CIAPIN1 signaling in vascular smooth muscle cells by Joo-Hui Han, Jong-Beom Heo, Hyung-Won Lee, Min-Ho Park, Jangmi Choi, Eun Joo Yun, Seongpyo Lee, Gyu Yong Song, Chang-Seon Myung

Subjects: Get full text

Mesenchymal stem cell-derived exosomes improve vascular remodeling by inhibiting EGFR/ErbB2 heterodimerization in hypoxic pulmonary hypertension by Yao-Xin Chen, Zhi-Hua Deng, Xiao-Wei She, Xue Gao, Xia-Ying Wei, Guo-Xing Zhang, Jin-Xian Qian

Subjects: Get full text